Jeffrey Bennett, MD

Associate Professor of Clinical Psychiatry, Department of Psychiatry Chair - St. John's Hospital
Psychiatry

    About me

    Dr. Jeffrey I. Bennett joined the faculty at Southern Illinois University School of Medicine as an Assistant Professor of Psychiatry and Director of the Department of Psychiatry Residency Program in 2003.  He has since held several posts (Director, Division of Developmental Disabilities; Psychiatry Clerkship Director, and Director, Division of Adult Services).  In 2014, he became the Donnelly Family Endowed Professor in Developmental Disabilities and subsequently an SIU SOM Academy Scholar 2015.

    Dr. Bennett completed medical school at New York University School of Medicine (1986) followed by a one-year Research Fellowship in Neurology at the University of Maryland Medical Center in Baltimore (1987). He completed his Psychiatry Residency at the University of Chicago (1991) after a medical internship at Michael Reese Hospital.  He subsequently finished a one year Fellowship in Neuropsychiatry (1992), becoming faculty at the University of Chicago (1993-2003).  He earned his bachelor's degree at Harvard University in Cambridge, Massachusetts (1978) followed by a year as a Research Associate in the Neurobiology Division at the University of California, San Francisco with Michael Dennis, Steve Hauser, and Leah Ziskind-Conhaim.

    While an Instructor at the University of Chicago, he also served as a Neuropsychiatric Consultant for Tinley Park Mental Health Center and Midwest Neurological Rehabilitation Center in Waterford, Wisconsin (1992-93). He also consulted for W.A. Howe Development Center in Tinley Park, Illinois (1992-94).  He served as Medical Director at Jacksonville Developmental Center (2011-2012).

    He is board certified in psychiatry. He currently serves as Immediate Past President for the Illinois Psychiatric Society.  He is a delegate to the Illinois State Medical Society, an Area 4 Representative to the American Psychiatric Association Assembly, and a member of the American Psychiatric Association Telepsychiatry and Membership Committees.  He is a member of American Neuropsychiatric Association, American Medical Association, and Association for Academic Psychiatry.

    Videos

    Remote video URL

    Gender

    Male

    Education & training

    Positions
    Clinical Psychiatrist
    Board Certifications
    Psychiatry
    Medical School
    New York University School of Medicine, New York, NY
    Residency
    University of Chicago Hospitals, Chicago, IL - Psychiatry
    Fellowship
    University of Chicago Hospitals, Chicago, IL - Neuropsychiatry
    University of Maryland Medical Center - Neurology Research

    Research

    Research Interests
    Neuropsychiatric disorders such as intellectual disabilities and neurodevelopmental disorders, dementia, delirium, epilepsy accompanied by psychiatric or behavioral syndromes, behavioral and psychological effects from traumatic brain injury.

    Publications

    Bennett, JI, Handa, K, Mahajan, A, Deotale, P.  Psychiatry Chief Resident Opinions 241-144.

    Khurshid, KA, Bennett, JI, Vicari, S, Lee, KL, Broquet, KE.  Residency Programs and Psychotherapy Competencies: A Survey of Chief Residents.  Acad Psychiatry 29:452-458, 2005.

    Ziskind-Conhaim, L, Bennett, JI.  The Effects of Electrical Inactivity and Denervation on the Distribution of Acetylcholine Receptors in Developing Rat Muscle. Dev Biol 90:185-197, 1982

    Bergey, GK, Habig, WH, Bennett, JI, Lin, CS.  Proteolytic Cleavage of Tetanus Toxin Increases Activity.  J. Neurochem 53:155-161, 1989.

    Bennett, JI, Goldman, LS.  Psychiatric Emergencies.  Chapter 4 in Goldman, LS, Wise, TN, Brody, DS. (eds).  Psychiatry for Primary Care Physicians.  American Medical Association, (November, 2003).

    “Non-Convulsive Status Epilepticus in a Woman with Psychosis and Epilepsy Treated with Clozapine.” Bennett, JI, Dusad, A.  Poster presentation at the American Neuropsychiatric Association Annual Meeting, Seattle, Washington

    “Case Report: An Elderly Woman with Rapidly Fluctuating Psychotic Symptoms and Frontal Meningioma.” Khan, M, Bennett, JI. Poster presentation at the American Neuropsychiatric Association Annual Meeting, Seattle, Washington

    “Excessive Writing in a Man with Traumatic Brain Injury: Case Report and Discussion of Hypergraphia.” Bennett, JI, Uga, A. Poster presentation at the American Neuropsychiatric Association Annual Meeting, Seattle, Washington

    Awards

    Irma Bland Award for Excellence in Teaching Residents American Psychiatric Association

    Donnelly Family Professorship in Developmental Disabilities

    Academy Scholar, Outstanding Achievement in Telepsychiatry Award Illinois Psychiatric Society 2014

    Medical Innovators 2013 Award Sangamon County Medical Society

     

    Clinical trials

    Trial
    Psychiatry

    ImpactTD Registry: A prospective multicenter study to characterize the natural history of tardive dyskinesia (TD) and investigate the real-world effectiveness of deutetrabenazine on the multidimensional impact of TD

    Active recruiting

    TV50717-CNS-40223: The purpose of this study is to get a better understanding of the disease course of tardive dyskinesia and the impact it has on individuals’ lives. In subjects who may begin on deutetrabenazine (AUSTEDO®) treatment during the study, it will also help investigate the real-world effectiveness of this treatment, particularly on a person’s quality of life.

    Trial
    Psychiatry

    RECOVER: A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No-Stimulation Control in Subjects with Treatment-Resistant Depression

    Active recruiting

    The RECOVER study is a nationwide clinical trial that has been approved by Medicare to provide additional evidence for the benefits of Vagus Nerve Stimulation (VNS) Therapy.  Vagus Nerve Stimulation Therapy is an FDA-approved device for treating patients with TRD (Treatment Resistant Depression). It is implanted in the left chest area during a short outpatient procedure. The device delivers mild, intermittently pulsed signals to the vagus nerve in the neck that activate various parts of the brain.